Siponimod approved for secondary progressive multiple sclerosis Published: 20 October 2020 A drug which was rejected by the National Institute for Health & Care Excellence (NICE) in June has now been approved for use on the NHS in England and Wales as the first ever oral treatment for secondary progressive